36 Medidata Solutions Testimonials

“Everything is there in one place. We can filter by site, we can filter by what’s been dispensed, and it’s really easy for us to track.”

“We used to do all the reconciliation manually. With the Rave Site Payment, it’s automated the payments not only from a sponsor’s perspective but also from the site’s perspective. Sites don’t have to do anything additional. From a sponsor perspective, we have all the line item details. We can see what’s paid to the site [and] what’s outstanding. The same applies to the sites. They can go into the system, see what’s been paid and what’s outstanding, and then work collaboratively to fix or expedite things if needed.”

“We chose to partner with Medidata because we recognize that we need an innovative technology partner with deep understanding of CROs and sites and sponsors in order for us to excel in this market. Medidata delivers the right platform, expertise and services that will allow us to be competitive and aggressively scale our full service offerings.”

“Medidata’s choice to implement the Rave eCOA/ ePRO solution in a unified environment with Rave EDC allows the user to extend their study design knowledge and ease the ePRO design, especially for beginners.“

“We don’t compromise on quality, and we are always innovating and striving for improvement. In Medidata, we have found a technology partner that does the same. Medidata is renowned as one of the best companies in terms of technological solutions for clinical trials.”

“The partnership with Medidata further underscores TissueTech’s commitment to evidence-based medicine, scientific integrity and continuous research and innovation. Medidata’s unified platform provides us with the technology foundation to scale our clinical research, address the complexity of today’s clinical trials, and build and maintain efficiencies as we continue to grow.”

“Medidata AI literally rolled up their sleeves, helped us analyze the data, and suggested ways to improve our clinical trial design. They were essentially part of our statistical group. We worked with Medidata and leveraged that information when we went to the FDA.”

"We needed to find a trusted partner to work with us, to grow with us AND deliver and provide innovative technology solutions for our clinical trials, we found that partner in Medidata."

“One of the things that attracted me to Medidata was their ability to have a support mechanism [beyond] internal experts. Having a broad reach across the globe and supporting end users with devices are important. These factors attracted me to the Medidata DCT Program because not all competitors have that reach with their help desk and device support. It’s nice to have a reputable organization that allows us to lean on."

"Edge Payments stood out as a true end-to-end solution, and for its ability to reimburse sites quickly and accurately by directly integrating with Rave EDC– important as we invest in processes and technology that help us continue to stand out as a top-ranked performer for service and customer loyalty.”

“Visibility into patient reporting helps us mitigate protocol compliance issues early in the study rather than later, when it’s harder.”

"The Medidata products are very innovative and support our very complex oncology studies."

"Using MS Word documents for visit reporting wasted our CRAs’ time and the reviewer’s time. With Medidata’s cloud-based CTMS, which structures visit report data, CRAs spend 40 percent less time completing a report and site correspondences. We’ve also noticed a reduction in review-to-approval cycle times from 16 days to seven days."

"Adopting Medidata's machine-learning capabilities for centralized monitoring will not only put us in line with the updated ICH E6 R2 guidelines, but will also allow us to view clinical information at a more holistic level, better prioritize trial resources, and maintain data quality and integrity."

“By using a system - that both the pharmaceutical industry recognizes, and the regulators accept - to execute high quality clinical trials, our mission to bring better treatments to patients faster can, ultimately, be realized.”